Brevan Howard Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,333	Closed	-$314K	–	1092
2024 Q4	$314K	Buy	1,333 +44	+3%	+$10.4K	﹤0.01%	728
2024 Q3	$355K	Buy	+1,289	New	+$355K	﹤0.01%	735